CLAY B. SIEGALL

Insider Reports History

Location
Bothell, WA
Signature
/s/ Sandra Stoneman, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by CLAY B. SIEGALL:

Company Role Class Num Shares Value Price $ Report Date Ownership
Seagen Inc. President & CEO, Director Common Stock 666,060 $152,527,740 $229.00 12 May 2022 Direct
Immunome Inc. President and CEO, Director Common Stock 665,254 $14,070,122 $21.15 30 Dec 2025 Direct
Shattuck Labs, Inc. Director Common Stock 128,054 $111,112 $0.8677 25 Aug 2025 Direct
Immunome Inc. President and CEO, Director Employee Stock Option (right to buy) 800,000 29 Jul 2025 Direct
Shattuck Labs, Inc. Director Warrants (Right to Buy) 128,054 25 Aug 2025 Direct
Seagen Inc. President & CEO, Director Non-Qualified Stock Option (right to buy) 51,129 12 May 2022 Direct
Shattuck Labs, Inc. Director Stock Option (Right to Buy) 33,150 14 Jul 2025 Direct
Nurix Therapeutics, Inc. Director Director Stock Option (right to buy) 17,500 05 May 2022 Direct
Tourmaline Bio, Inc. Director Stock Option (Right to Buy) 16,800 04 Jun 2025 Direct
Tourmaline Bio, Inc. Director Employee Stock Option (Right to Buy) 0 28 Oct 2025 Direct

Insider Reports Filed by CLAY B. SIEGALL

Symbol Company Period Transactions Value $ Form Type Role Filing Time
IMNM Immunome Inc. 30 Dec 2025 1 +$100,018 4 President and CEO, Director 30 Dec 2025, 18:47
IMNM Immunome Inc. 19 Dec 2025 2 +$149,053 4 President and CEO, Director 22 Dec 2025, 07:38
IMNM Immunome Inc. 18 Dec 2025 1 +$999,986 4 President and CEO, Director 18 Dec 2025, 17:03
TRML Tourmaline Bio, Inc. 28 Oct 2025 3 $0 4 Director 28 Oct 2025, 18:30
STTK Shattuck Labs, Inc. 25 Aug 2025 2 +$111,112 4 Director 27 Aug 2025, 06:30
IMNM Immunome Inc. 29 Jul 2025 1 $0 4 President and CEO, Director 31 Jul 2025, 18:51
STTK Shattuck Labs, Inc. 14 Jul 2025 1 $0 4 Director 16 Jul 2025, 16:28
TRML Tourmaline Bio, Inc. 04 Jun 2025 1 $0 4 Director 06 Jun 2025, 16:33
IMNM Immunome Inc. 26 Mar 2025 1 +$999,459 4 President and CEO, Director 26 Mar 2025, 16:03
IMNM Immunome Inc. 31 Jan 2025 1 +$1,162,500 4 President and CEO, Director 03 Feb 2025, 21:01
IMNM Immunome Inc. 21 Nov 2024 2 +$962,181 4 President and CEO, Director 25 Nov 2024, 08:41
IMNM Immunome Inc. 09 Aug 2024 1 $0 4 President and CEO, Director 13 Aug 2024, 17:56
STTK Shattuck Labs, Inc. 21 Jun 2024 1 $0 4 Director 21 Jun 2024, 18:12
TRML Tourmaline Bio, Inc. 05 Jun 2024 1 $0 4 Director 07 Jun 2024, 16:03
IMNM Immunome Inc. 20 May 2024 2 +$1,388,072 4 President and CEO, Director 21 May 2024, 16:13
STTK Shattuck Labs, Inc. 06 Mar 2024 1 $0 4 Director 08 Mar 2024, 17:38
STTK Shattuck Labs, Inc. 01 Mar 2024 0 $0 3 Director 08 Mar 2024, 17:30
TRML Tourmaline Bio, Inc. 13 Dec 2023 1 $0 4 Director 15 Dec 2023, 16:23
TRML Tourmaline Bio, Inc. 13 Dec 2023 0 $0 3 Director 15 Dec 2023, 16:21
IMNM Immunome Inc. 02 Oct 2023 1 +$999,996 4 President and CEO, Director 04 Oct 2023, 17:35
IMNM Immunome Inc. 02 Oct 2023 0 $0 3 President and CEO, Director 04 Oct 2023, 17:34
/report/000120331122000035-siegall-clay-b-2022-05-12 Seagen Inc. 12 May 2022 6 -$1,697,295 4 President & CEO, Director 13 May 2022, 19:13
NRIX Nurix Therapeutics, Inc. 05 May 2022 1 $0 4 Director 06 May 2022, 17:43
/report/000120331122000033-siegall-clay-b-2022-04-20 Seagen Inc. 20 Apr 2022 1 -$272,041 4 President & CEO, Director 22 Apr 2022, 20:34
/report/000089924322014397-siegall-clay-b-2022-04-07 Seagen Inc. 07 Apr 2022 21 -$2,183,788 4 President and CEO, Director 08 Apr 2022, 21:41
/report/000120331122000018-siegall-clay-b-2022-03-07 Seagen Inc. 07 Mar 2022 15 -$1,844,833 4 President & CEO, Director 09 Mar 2022, 18:42
/report/000120331122000014-siegall-clay-b-2022-02-07 Seagen Inc. 07 Feb 2022 15 -$1,940,744 4 President & CEO, Director 09 Feb 2022, 18:02
/report/000120331122000004-siegall-clay-b-2022-01-07 Seagen Inc. 07 Jan 2022 12 -$2,021,895 4 President & CEO, Director 11 Jan 2022, 18:14
/report/000120331121000099-siegall-clay-b-2021-12-20 Seagen Inc. 20 Dec 2021 1 -$183,866 4 President & CEO, Director 22 Dec 2021, 16:32
/report/000120331121000090-siegall-clay-b-2021-12-07 Seagen Inc. 07 Dec 2021 15 -$5,570,413 4 President & CEO, Director 09 Dec 2021, 17:49
/report/000120331121000078-siegall-clay-b-2021-09-23 Seagen Inc. 23 Sep 2021 1 +$118,681 4 President & CEO, Director 27 Sep 2021, 20:10
/report/000089924321034984-siegall-clay-b-2021-08-31 Seagen Inc. 31 Aug 2021 2 -$2,404,015 4 President & CEO, Director 02 Sep 2021, 19:59
/report/000089924321034676-siegall-clay-b-2021-08-27 Seagen Inc. 27 Aug 2021 6 -$10,146,781 4 President and CEO, Director 31 Aug 2021, 21:28
/report/000120331121000064-siegall-clay-b-2021-08-16 Seagen Inc. 16 Aug 2021 4 -$431,051 4 President & CEO, Director 18 Aug 2021, 20:29
/report/000120331121000051-siegall-clay-b-2021-08-05 Seagen Inc. 05 Aug 2021 18 -$4,313,422 4 President & CEO, Director 06 Aug 2021, 20:28
/report/000089924321027729-siegall-clay-b-2021-07-01 Seagen Inc. 01 Jul 2021 21 -$4,155,811 4 President and CEO, Director 06 Jul 2021, 21:40
/report/000120331121000044-siegall-clay-b-2021-06-03 Seagen Inc. 03 Jun 2021 21 -$3,788,003 4 President and CEO, Director 04 Jun 2021, 20:22
NRIX Nurix Therapeutics, Inc. 28 May 2021 1 $0 4 Director 01 Jun 2021, 16:21
NRIX Nurix Therapeutics, Inc. 28 May 2021 0 $0 3 Director 01 Jun 2021, 16:19
/report/000120331121000020-siegall-clay-b-2021-05-06 Seagen Inc. 06 May 2021 9 -$3,508,026 4 President and CEO, Director 07 May 2021, 18:29